相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers
Manon Suerink et al.
GENETICS IN MEDICINE (2016)
Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection
Elizabeth H. Blackburn et al.
SCIENCE (2015)
VHL, the story of a tumour suppressor gene
Lucy Gossage et al.
NATURE REVIEWS CANCER (2015)
Telomere Shortening Is Associated with Genetic Anticipation in Chinese Von Hippel-Lindau Disease Families
Xiang-hui Ning et al.
CANCER RESEARCH (2014)
Telomere Length as a Risk Factor for Hereditary Prostate Cancer
Lauren M. Hurwitz et al.
PROSTATE (2014)
A Prospective Study of Leukocyte Telomere Length and Risk of Renal Cell Carcinoma
Jonathan N. Hofmann et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Genotype-phenotype correlation in MMR mutation-positive families with Lynch syndrome
Lucia Perez-Cabornero et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
Family history of von Hippel-Lindau disease was uncommon in Chinese patients: suggesting the higher frequency of de novo mutations in VHL gene in these patients
Pengjie Wu et al.
JOURNAL OF HUMAN GENETICS (2012)
Shorter telomere length is associated with increased ovarian cancer risk in both familial and sporadic cases
Beatriz Martinez-Delgado et al.
JOURNAL OF MEDICAL GENETICS (2012)
Epidemiologic evidence for a role of telomere dysfunction in cancer etiology
Jennifer Prescott et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2012)
Risk of renal cell carcinoma in relation to blood telomere length in a population-based case-control study
J. N. Hofmann et al.
BRITISH JOURNAL OF CANCER (2011)
von Hippel-Lindau disease: A clinical and scientific review
Eamonn R. Maher et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Genotype-Phenotype Correlations in VHL Exon Deletions
Alisdair McNeill et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Telomere Length in Peripheral Blood Predicts Survival in Clear Cell Renal Cell Carcinoma
Ulrika Svenson et al.
CANCER RESEARCH (2009)
Neurologic manifestations of von Hippel-Lindau disease
John A. Butman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer
Lina Shao et al.
JOURNAL OF UROLOGY (2007)
Loss of the actin regulator HSPC300 results in clear cell renal cell carcinoma protection in von Hippel-Lindau patients
Alberto Cascon et al.
HUMAN MUTATION (2007)
Genotype-phenotype correlations in von Hippel-Lindau disease
Kai Ren Ong et al.
HUMAN MUTATION (2007)
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology
AK Meeker
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2006)
Genotype phenotype correlation in Li-Fraumeni syndrome kindreds and its implications for management
R. N. Moule et al.
FAMILIAL CANCER (2006)
Telomeres and human disease: Ageing, cancer and beyond
MA Blasco
NATURE REVIEWS GENETICS (2005)
Tumors of the endolymphatic sac in von Hippel-Lindau disease
RR Lonser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions
C Gallou et al.
HUMAN MUTATION (2004)
Telomere measurement by quantitative PCR
RM Cawthon
NUCLEIC ACIDS RESEARCH (2002)
分享论文
